Lynley V. Marshall

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren et al. · The Lancet Oncology · 2019 · 324 citations

Interim Analysis, Lymphoid Neoplasia, Surgical Oncology +10

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

Matthew Clarke, Alan Mackay, Britta Ismer et al. · Cancer Discovery · 2020 · 264 citations · Full text

Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells

Maria Vinci, Anna Burford, Valeria Molinari et al. · Nature Medicine · 2018 · 178 citations · Full text

Neuro-oncology, Pediatric Brain Tumors, Subclonal Populations +12

Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study

Birgit Geoerger, C. Michel Zwaan, Lynley V. Marshall et al. · The Lancet Oncology · 2019 · 162 citations

Hematological Malignancy, Lymphoid Neoplasia, Hodgkin Lymphoma +7

MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase–Mediated <i>HOX</i>/Stem Cell Gene Signature

Nathalie Gaspar, Lynley V. Marshall, Lara Perryman et al. · Cancer Research · 2010 · 158 citations · Full text

High-grade Gliomas, Cancer Biology, Glioma +16